Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy Meeting Abstract
| Authors: | Gavane, S. C.; Ito, K.; Moskowitz, C. H.; Moskowitz, A. J.; Schoder, H. |
| Abstract Title: | Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 602s |
| Language: | English |
| ACCESSION: | WOS:000404712500569 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.11566 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11566 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
